Latest Breaking News On - Hua medicine shanghai ltd - Page 1 : comparemela.com

Hua Medicine (Shanghai) Ltd (OTCMKTS:HUMDF) Short Interest Up 7 1% in August

Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 15th, there was short interest totalling 828,400 shares, a growth of 7.1% from the July 31st total of 773,400 shares. Based on an average daily volume of 0 […]

Hua medicine shanghai ltdHua medicine shanghai company profileHua medicineGet free reportHua medicine shanghaiOtcmkts humdf

Hua Medicine (Shanghai) Ltd (OTCMKTS:HUMDF) Short Interest Update

Hua Medicine (Shanghai) Ltd (OTCMKTS:HUMDF) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hua medicine shanghai company profileHua medicine shanghai ltdHua medicineGet free report

Global Type 2 Diabetes Market Outlook to 2029 - The US Market Will Contribute the Most with $57B in Sales by 2029 (62% of the Global Industry)

Share: ResearchAndMarkets.com s offering. Based on epidemiological analysis, the number of diagnosed prevalent cases of T2D will grow by 28.76% over the forecast period, at an AGR of 2.3%, from 164,826,095 cases in 2018 to 216,029,212 cases by 2029 across the nine major pharmaceutical markets covered in this report, the US, 5EU (France, Germany, Italy, Spain and UK), Japan, India and China. The report projects that the marketplace for T2D within the 9MM will grow from $48bn in 2019 at a compound annual growth rate (CAGR) of 6.7% to $91.9B by 2029. In particular, the report expects the US market will contribute the most to the antidiabetic market s growth, contributing sales in $28B sales in 2019 (58% of the global antidiabetic market) and $57B in 2029 (62% of the global antidiabetic market).

United kingdomOramed pharamceuticalsEli lillyLaura woodBoehringer ingelheimMerck coHua medicine shanghai ltdBiocon ltdSihuan pharmaceutical holdings group ltdJiangsu hengrui medicine coCustom researchD developers battle for shareLexicon pharmaceuticalsOffice hours callCompany profilesE st office hours call